
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
In this book, a group of distinguished contributors review the epidemiology, biological basis, and current treatments of panic disorder. Particular emphasis is given to new findings on the co-morbidity of panic, especially with depression. The most up-to-date information on the biochemical events involved in the provocation of panic attacks is presented, and the roles of serotonin, cholecystokinin, GABA, and noradrenalin are examined in detail. This knowledge opens up possibilities for novel treatments for panic disorder, and their potential is assessed by the contributors. It is only relatively recently that panic has been classified as a distinct psychiatric disorder and it now appears in the International Classification of Disease in ICD10.
This monograph investigates the biological mechanisms, epidemiological patterns, and pharmacological treatment strategies associated with panic disorder. Edited by Stuart A. Montgomery, the text compiles contributions from clinical researchers to synthesize current understanding of the disorder's biochemical underpinnings. The work frames panic as a distinct psychiatric entity, evaluating how neurotransmitter systems influence clinical outcomes and the development of therapeutic interventions.
What You Will Find
Scope Limits
Experts recognize this volume as a specialized resource for clinicians and researchers focusing on the biological basis of anxiety disorders. Readers frequently note the technical density of the prose, which assumes a foundational knowledge of neurochemistry and psychiatric diagnostic standards.
Page Count:
160
Publication Date:
1993-02-25
Publisher:
Oxford University Press
ISBN-10:
0192620878
ISBN-13:
9780192620873
No comments yet. Be the first to share your thoughts!